SynopsisThe global market for Aptamers was valued at US$ 341 million in the year 2024 and is projected to reach a revised size of US$ 1138 million by 2031, growing at a CAGR of 19.0% during the forecast period. Aptamers are high affinity molecules that are deriv.....
SynopsisThe global market for Digital Pathology was valued at US$ 931 million in the year 2024 and is projected to reach a revised size of US$ 2178 million by 2031, growing at a CAGR of 13.1% during the forecast period. Digital Pathology, which also refers as vi.....
SynopsisThe global market for GxP Auditing Services was valued at US$ 731 million in the year 2024 and is projected to reach a revised size of US$ 1008 million by 2031, growing at a CAGR of 5.4% during the forecast period. GxP Auditing Services offer compliance .....
SynopsisThe global market for Circle Acute Ischemic Stroke was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period. Acute ischemic stroke occurs when blood flow .....
SynopsisThe global market for Bare Metal Stents was valued at US$ 638 million in the year 2024 and is projected to reach a revised size of US$ 761 million by 2031, growing at a CAGR of 2.6% during the forecast period. This report studies the Bare Metal Stent mar.....
SynopsisThe global market for Mouthguard was valued at US$ 248 million in the year 2024 and is projected to reach a revised size of US$ 393 million by 2031, growing at a CAGR of 6.9% during the forecast period. A mouthguard is a protective device for the mouth t.....
SynopsisThe global market for Digital Dialysate Meter was valued at US$ 112 million in the year 2024 and is projected to reach a revised size of US$ 166 million by 2031, growing at a CAGR of 5.8% during the forecast period. The digital dialysate meter is a medic.....
SynopsisThe global market for PARP (Poly ADP-Ribose Polymerase) Inhibitor was valued at US$ 5551 million in the year 2024 and is projected to reach a revised size of US$ 9999 million by 2031, growing at a CAGR of 8.9% during the forecast period. PARP inhibitors .....
SynopsisThe global market for Eptifibatide was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period. North American market for Eptifibatide is estimated to increa.....
SynopsisThe global market for Sickle Cell Anemia Therapeutics was valued at US$ 4467 million in the year 2024 and is projected to reach a revised size of US$ 12230 million by 2031, growing at a CAGR of 15.7% during the forecast period. Sickle cell disease (SCD) .....
